- Home
- Managing Physical Occupational Speech Therapy and Rehabilitation Care Edition Update
Managing Physical Occupational Speech Therapy and Rehabilitation Care Edition Update
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 53 pages
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 56 pages
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 54 pages
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 54 pages
Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: World, Europe, United States, Spain, Italy, France, Germany, Japan, United Kingdom
Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 54 pages
Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom
Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 50 pages
Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: World, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022
- $ 3 995
- Industry report
- by Global Data
- May 2013
- 46 pages
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence of one to three cases per 100,000 population worldwide (Giuliani et al., 2006). Strains of ...
Industries: Pathology | Countries: World, Australia, Brazil, Spain, United States, United Kingdom, Italy, France, Germany
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease
- $ 3 500
- Industry report
- by GBI Research
- May 2013
- 134 pages
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease Summary GBI Research's report ?Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) ...
Industries: Pathology | Countries: Australia, Japan, United States, India, World, Europe, China
ViroPharma Patent Survey 2013
- $ 613
- Company report
- by KnowMade
- May 2013
- 42 pages
ViroPharma Incorporated, a pharmaceutical company, develops and sells drugs that address serious diseases treated by physician specialists and in hospital settings. The company focuses on product development activities on virus and human disease, including those caused by cytomegalovirus (CMV) and hepatitis ...
Industries: Pathology | Countries: United States
Oxford Gene Technology - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- by Global Data
- May 2013
- 36 pages
Summary Oxford Gene Technology (OGT) is a biotechnology company. The company develops biomarkers. Its products include hematological cancer +SNP array, ISCA arrays, ISCA + SNP array, ISCA UPD array, ISCA sample tracking spike-ins, syndrome plus v2 array, molecular testing arrays and panels, DMD array, ...
Industries: Pathology | Countries: United States
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- 00 1 718 618 48 97
ref:plp2012
Reportlinker.com © Copyright 2013. All rights reserved.
